IL60025A - Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them - Google Patents

Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them

Info

Publication number
IL60025A
IL60025A IL60025A IL6002580A IL60025A IL 60025 A IL60025 A IL 60025A IL 60025 A IL60025 A IL 60025A IL 6002580 A IL6002580 A IL 6002580A IL 60025 A IL60025 A IL 60025A
Authority
IL
Israel
Prior art keywords
xanthines
preparation
pharmaceutical compositions
compositions containing
certain new
Prior art date
Application number
IL60025A
Other languages
English (en)
Other versions
IL60025A0 (en
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of IL60025A0 publication Critical patent/IL60025A0/xx
Publication of IL60025A publication Critical patent/IL60025A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL60025A 1979-05-22 1980-05-08 Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them IL60025A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4780/79A CH654008A5 (fr) 1979-05-22 1979-05-22 Procede de preparation de 1,3,7-trialkylxanthines.

Publications (2)

Publication Number Publication Date
IL60025A0 IL60025A0 (en) 1980-07-31
IL60025A true IL60025A (en) 1984-10-31

Family

ID=4282410

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60025A IL60025A (en) 1979-05-22 1980-05-08 Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (2) US4299833A (xx)
EP (1) EP0019165B1 (xx)
JP (2) JPS55154973A (xx)
CH (1) CH654008A5 (xx)
DE (1) DE3070919D1 (xx)
ES (1) ES491683A0 (xx)
GB (1) GB2052480B (xx)
HK (1) HK13984A (xx)
HU (1) HU184280B (xx)
IL (1) IL60025A (xx)
MY (1) MY8400259A (xx)
PH (1) PH17503A (xx)
SG (1) SG29483G (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH643260A5 (fr) * 1980-05-02 1984-05-30 Nestle Sa 1-allyl-3-butyl-8-methylxanthine, procede de preparation et utilisation dans un medicament.
IT1200944B (it) * 1982-08-10 1989-01-27 Malesci Sas Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
AU607709B2 (en) * 1986-08-07 1991-03-14 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg A micelle containing a hydrophobic pharmaceutically active substance
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
NZ240644A (en) * 1990-11-21 1994-08-26 Smithkline Beecham Corp Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
IT1258944B (it) * 1992-06-22 1996-03-08 Emilio Toja Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
TW225535B (xx) * 1992-11-10 1994-06-21 Hoechst Ag
JP2008546752A (ja) * 2005-06-21 2008-12-25 ザ ユニヴァーシティー コート オブ ザ ユニヴァーシティー オブ ダンディー インヒビター化合物
KR20090115953A (ko) * 2007-03-06 2009-11-10 노파르티스 아게 염증성 또는 알레르기성 상태의 치료에 적합한 바이시클릭 유기 화합물
CN101220032B (zh) * 2007-12-14 2010-06-02 百利高贸易（上海）有限公司 3_甲基黄嘌呤二钠盐甲化制备可可碱的新方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH4780A (fr) 1892-04-05 1892-07-30 Emile Bauer Nouveau système de machine à détente
US631757A (en) * 1898-02-18 1899-08-22 Boehringer & Soehne Xanthin derivative and process of making same.
US631760A (en) * 1898-03-04 1899-08-22 Boehringer & Soehne Alkylized xanthin and process of making same.
US2523496A (en) * 1948-10-21 1950-09-26 Kenneth N Campbell Method of preparing xanthine and methylated xanthines
GB706424A (en) * 1950-05-17 1954-03-31 Hoechst Ag Manufacture of xanthine and its alkyl derivatives
US3740433A (en) * 1971-10-01 1973-06-19 Squibb & Sons Inc Anti-anxiety composition and method of use
DE2714953C2 (de) * 1977-04-02 1986-09-25 Hoechst Ag, 6230 Frankfurt Arzneimittel

Also Published As

Publication number Publication date
SG29483G (en) 1985-01-11
HU184280B (en) 1984-07-30
MY8400259A (en) 1984-12-31
JPS55154973A (en) 1980-12-02
GB2052480A (en) 1981-01-28
US4299833A (en) 1981-11-10
JPH01199972A (ja) 1989-08-11
PH17503A (en) 1984-09-07
DE3070919D1 (en) 1985-09-05
US4450163A (en) 1984-05-22
JPH0210835B2 (xx) 1990-03-09
EP0019165A1 (fr) 1980-11-26
IL60025A0 (en) 1980-07-31
CH654008A5 (fr) 1986-01-31
HK13984A (en) 1984-02-24
EP0019165B1 (fr) 1985-07-31
ES8104290A1 (es) 1981-04-16
GB2052480B (en) 1983-03-16
ES491683A0 (es) 1981-04-16

Similar Documents

Publication Publication Date Title
MY8500062A (en) 1,2,4-troazome deriovatives, process for preparing such compounds and pharmaceutical compositions containing them
DE3064173D1 (en) Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them
IL57020A0 (en) New carbazolyl-(4)-oxypropanolamine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
PT76809A (en) Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same
PT76657A (en) Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same
GB2063874B (en) Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them
IL60025A (en) Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them
IL57213A (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
GB2050833B (en) Pharmaceutical compositions and process for the preparation thereof
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
DE2964803D1 (en) 2-azaergolines and 2-aza-8(or 9)-ergolenes, process for their preparation and pharmaceutical compositions containing them
IL61175A0 (en) 1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them
PT72066A (en) Process for the preparation of novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof
PT79389A (en) Process for the preparation of 1,2-dithyolane derivates and pharmaceutical compositions containing said derivates
DE3060079D1 (en) Spiro-quinolylhydantoins, process for their preparation and pharmaceutical compositions thereof
DE3062972D1 (en) Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
IL54111A (en) 3,6-disubstituted-1,2,4-triazine-5-one-derivatives,process for their preparation and pharmaceutical compositions containing them
IL60907A0 (en) Substituted quinoline-alkanecarboxylic acids,process for their preparation and pharmaceutical compositions containing them
PT71211A (en) Process for the preparation of 3-substituted-tetrahydropyrrolo/1,2-a/pyrimidines and pharmaceutical compositions containing the same and new 3-substituted-tetrahydro-pyrrolo/1,2-a/ pyrimidines
EP0018077A3 (en) Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines
IL61099A (en) 9-deoxy-6,9alpha-imino-delta6,8-pgi analogues,process for their preparation and pharmaceutical compositions containing them
PT77282B (en) Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same
PT74400B (en) Process for the preparation of 17,18-dehydro-apovincaminol-3', 4',5'-trimethoxy-benzoate and of pharmaceutical compositions containing them
DE2861570D1 (en) 17 alpha-aryl or 17 alpha-heteroaryl steroids, process for their preparation, their use as medicines and pharmaceutical compositions containing them